Cresco Labs (CRLBF) Depreciation & Amortization (CF) (2019 - 2026)

Cresco Labs (CRLBF) posted Depreciation & Amortization (CF) of $12.2 million for Q1 2026, up 13.53% on a QoQ basis from $10.8 million in Q4 2025, and down 5.35% year-over-year from $12.9 million in Q1 2025.

Cresco Labs (CRLBF) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Cresco Labs' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $12.2 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 5.35% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.0 million (down 15.27% YoY) and the FY2025 annual result came in at $48.7 million, down 17.57% from the prior year.
  • Depreciation & Amortization (CF) was $12.2 million for Q1 2026 at Cresco Labs, up from $10.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $20.3 million in Q4 2023 and bottomed at $10.8 million in Q4 2025.
  • A 5-year average of $13.8 million and a median of $13.4 million in 2022 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 40.04% — and 2024, when it tumbled 31.35%.
  • Cresco Labs' Depreciation & Amortization (CF) stood at $14.5 million in 2022, then jumped by 40.04% to $20.3 million in 2023, then tumbled by 31.35% to $13.9 million in 2024, then fell by 22.62% to $10.8 million in 2025, then gained by 13.53% to $12.2 million in 2026.
  • Business Quant data shows CRLBF's Depreciation & Amortization (CF) at $12.2 million in Q1 2026, $10.8 million in Q4 2025, and $12.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn 12.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.22 Mn
Mar 31, 2026 12.22 Mn
Dec 31, 2025 10.76 Mn
Dec 31, 2025 10.76 Mn
Sep 30, 2025 12.86 Mn
Sep 30, 2025 12.86 Mn
Jun 30, 2025 12.19 Mn
Jun 30, 2025 12.19 Mn
Mar 31, 2025 12.91 Mn
Mar 31, 2025 12.91 Mn
Dec 31, 2024 13.90 Mn
Dec 31, 2024 13.90 Mn
Sep 30, 2024 14.93 Mn
Sep 30, 2024 14.93 Mn
Jun 30, 2024 14.93 Mn
Jun 30, 2024 14.93 Mn
Mar 31, 2024 15.33 Mn
Mar 31, 2024 15.33 Mn
Dec 31, 2023 20.25 Mn
Dec 31, 2023 20.25 Mn